Social Sciences · Health
Vaccine Hesitancy in Patients with Autoimmune Diseases- Data from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Study
Lilleker, James B.; id_orcid 0000-0002-9230-4137, Chinoy, Hector; id_orcid 0000-0001-6492-1288, et al.
See on the mapAbstract
The Coronavirus Disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be a obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalisation and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we examine the reasons for vaccine hesitancy, observed in approximately half the patients with autoimmune diseases in the preliminary results from the study.